A Mysterious Subungual Mass in an Elderly Man Authors: Prajakta Sharma, Rishabh Singhal, Balkrishna Nikam Published: 2026 A 67-year-old man presented to our outpatient department with an asymptomatic, slow-growing mass on his left thumb for 5 years. There was no history of preceding trauma. On examination, a partially eroded, painless subungual hyperkeratotic lesion associated with onychogryphosis was seen on the left thumb[Figure 1a and 1b]. There was a history of treatment with topical and oral antifungals, without any relief. All routine hematological and biochemical investigations were within normal limits. Dermoscopy was nonspecific and showed subungual hyperkeratosis and irregular brown-to-black pigmentation with asymmetry. An incisional biopsy was performed, which revealed a tumor composed of broad, interconnecting anastomosing islands of small cuboidal cells with rounded nuclei, admixed with some atypical large hyperchromatic cells. Cystic lumina and ductular structures were identified within the tumor nests [Figures 2a and 2b, 3a and 3b]. (a) A partially eroded subungual hyperkeratotic lesion. (b) Presence of nail dystrophy (a) Tumor connected to the surface epidermis at multiple points and is made up of interconnecting, broad anastomosing islands (Hematoxylin and eosin, 4×) (b) Clear demarcation of surface epidermis and tumor, connected at various points. (Hematoxylin and eosin, 100×) (a) Islands of poroid monomorphous cells with round nuclei (Hematoxylin and eosin, 100×) (b) Magnified view of atypical large hyperchromatic cells (blue arrow) with intracytoplasmic lumina formation (black arrow) (Hematoxylin and eosin, 400×) What is your diagnosis? Answer: Eccrine porocarcinoma Discussion Eccrine porocarcinoma, also known as malignant eccrine poroma, is a rare cutaneous malignancy derived from the dermal sweat gland and acrosyringium. This accounts for approximately 0.005%–0.01% of all cutaneous malignancies. It was first described as “epidermotropic eccrine carcinoma” by Pinkus and Mehregan in 1963; while, a few years later, Mishima and Morioka introduced the term “eccrine porocarcinoma”,[1] which is now most frequently used and was included in the 2018 World Health Organization classification of skin tumors. Typically, this tumor arises in midlife, occurring equally in males and females, and has been observed in all races. The most common sites include the head and neck and lower extremities. To the authors’ knowledge, only four cases of subungual porocarcinoma have been reported so far, including two in the fingers and two in the toes[2]; making the location in the present patient very rare. Porocarcinoma is usually asymptomatic, so patients tend to neglect it until it reaches an advanced stage or causes functional problems. In the early stages, the tumor may resemble common benign conditions, such as onychomycosis and viral warts, as in the present patient who received ineffective treatment for years. Long-standing cases may sometimes indicate malignant change in a poroma or hidroacanthoma simplex. It is important to differentiate subungual porocarcinomas from close differentials like squamous cell carcinoma (SCC) and melanoma. Duct formation and the presence of small cuboidal cells with oval to round nuclei (poroid cells) are important distinguishing features from SCC on histopathological examination.[3] Furthermore, the presence of variable amounts of periodic acid–Schiff staining material is seen in porocarcinomas, which is usually not the case in SCC. The presence of ductal differentiation and absence of pagetoid spread of atypical melanocytes help differentiate it from melanoma. Additionally, dermoscopic features such as the absence of irregularly spaced brown-black bands on the nail plate and micro-Hutchinson’s sign (pigmentation extending onto the nail cuticle, visible only on dermoscopy)[4] also help rule out melanoma. Information regarding immunohistochemical reactions in eccrine porocarcinoma is scarce. Epithelial markers such as carcinoembryonic antigen and epithelial membrane antigen are usually positive. CD117 positivity can help differentiate it from squamous cell carcinoma.[5] Higher proliferating cell nuclear antigen expression and aberrant p16 expression are sometimes seen in porocarcinomas compared to poromas. Podoplanin, frequently expressed by porocarcinomas, helps to differentiate them from metastatic adenocarcinomas to the skin. However, these investigations could not be conducted in our patient due to financial constraints. Definitive management of subungual porocarcinomas is surgical amputation[2] of the affected phalanx. However, microscopically controlled surgery using Mohs micrographic technique has also been employed in the management of subungual malignancies, allowing complete excision of the lesion while maximizing preservation of normal tissue and function. These modalities could not be performed in our patient as he was lost to follow-up. Local recurrences and metastasis, particularly to regional lymph nodes, have also been reported in some cases. With this report, the authors aim to emphasize the importance of physician awareness of this entity and the need to consider porocarcinoma in the differential diagnosis of subungual tumors. Authors’ contributions We confirm that all authors have read and approved the manuscript for submission. All authors meet authorship criteria, and the manuscript represents honest work. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published and due efforts will be made to conceal his identity, but anonymity cannot be guaranteed. Conflicts of interest There are no conflicts of interest. Use of artificial intelligence (AI) The preparation of this manuscript was carried out entirely by the authors without the use of artificial intelligence technologies.